1. Home
  2. FLGT vs UVE Comparison

FLGT vs UVE Comparison

Compare FLGT & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • UVE
  • Stock Information
  • Founded
  • FLGT 2011
  • UVE 1990
  • Country
  • FLGT United States
  • UVE United States
  • Employees
  • FLGT N/A
  • UVE N/A
  • Industry
  • FLGT Medical Specialities
  • UVE Property-Casualty Insurers
  • Sector
  • FLGT Health Care
  • UVE Finance
  • Exchange
  • FLGT Nasdaq
  • UVE Nasdaq
  • Market Cap
  • FLGT 697.3M
  • UVE 666.1M
  • IPO Year
  • FLGT 2016
  • UVE 1992
  • Fundamental
  • Price
  • FLGT $22.36
  • UVE $32.47
  • Analyst Decision
  • FLGT Buy
  • UVE
  • Analyst Count
  • FLGT 3
  • UVE 0
  • Target Price
  • FLGT $25.33
  • UVE N/A
  • AVG Volume (30 Days)
  • FLGT 199.8K
  • UVE 200.2K
  • Earning Date
  • FLGT 11-07-2025
  • UVE 10-23-2025
  • Dividend Yield
  • FLGT N/A
  • UVE 2.35%
  • EPS Growth
  • FLGT N/A
  • UVE 70.32
  • EPS
  • FLGT N/A
  • UVE 4.23
  • Revenue
  • FLGT $303,223,000.00
  • UVE $1,580,798,000.00
  • Revenue This Year
  • FLGT $15.19
  • UVE $1.87
  • Revenue Next Year
  • FLGT $10.58
  • UVE N/A
  • P/E Ratio
  • FLGT N/A
  • UVE $7.74
  • Revenue Growth
  • FLGT 4.31
  • UVE 4.61
  • 52 Week Low
  • FLGT $14.57
  • UVE $18.72
  • 52 Week High
  • FLGT $24.64
  • UVE $33.00
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 45.76
  • UVE 68.18
  • Support Level
  • FLGT $22.06
  • UVE $30.05
  • Resistance Level
  • FLGT $23.15
  • UVE $31.72
  • Average True Range (ATR)
  • FLGT 0.71
  • UVE 1.03
  • MACD
  • FLGT -0.12
  • UVE 0.11
  • Stochastic Oscillator
  • FLGT 17.05
  • UVE 87.41

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

Share on Social Networks: